Build status - In Progress

Study to evaluate antibody response to an additional dose of COVID-19 vaccination with and without immunosuppression reduction in kidney and liver transplant recipients.

Recruiting
18 years - 99 years
All
10 participants needed
1 Location

Brief description of study

The purpose of the study is to find out whether an extra dose of COVID-19 study dose of vaccine will help to protect people who have had a liver or kidney transplant from COVID-19 by causing their body to make antibodies against the virus that causes COVID-19. Many transplant recipients do not make antibodies after receiving 2 doses of the COVID-19 vaccine. This means that they are more likely to get infected with COVID-19. This study will help us learn whether an additional dose of COVID-19 study vaccine with or without lowering an anti-rejection medicine can help transplant recipients make more antibody to COVID-19.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Kidney,Liver,COVID-19
  • Age: 18 years - 99 years
  • Gender: All
Updated on 04 Aug 2024. Study ID: 850518

Find a site

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center